Terrex und Union Capital heute in Downunder wirklich am absteigen - schade !!

Umgerechnet Terrex bei ca. 0,07 E
UCL bei ca. 0,23 E.

What goes up must come down - aber in der Gegenrichtung sicherlich auch richtig. Abwarten ist angesagt.  

 

 

 

Ich kaufe erst wieder bei 0,06. Solange es die nicht schaffen Ihren Q-Bericht zu schreiben....  

Ich hatte Dich gestern gefragt, ob Du vom Börsenhandel lebst???? Aber Du
warst leider nicht mehr online. Wenn ja, melde Dich doch mal.....ich hätte gerne ein paar Anregungen!!!!
Wie ist die Stimmung in Australien denn so zum Thema Abador?? Sind die
auch so geil auf die Aktie wie die Leute hier in Germany????  

der q-bericht ist schon lange draußen, du mußt bei WO jetzt nur besser suchen "lol"  

TERREX RESOURCES LIMITED (TXR)
(Company background)
Fourth Quarter Activities & Cashflow Report
Announced on 2000/02/02 16:10:17.
Part:B 1075 words
Status: Market sensitive (Y)
Industry Sub Group: Gold Explorer (12)



TERREX RESOURCES LIMITED 2000-01-31 ASX-SIGNAL-G

HOMEX - Perth

+++++++++++++++++++++++++
ACQUISITION OF INTEREST IN GLOBAL DOCTOR LTD

In August 1999 the company announced the acquisition of a 60%
interest in the capital of Global Doctor Limited ("GDL"), a company
which intends to participate in the medical industry through the
provision of internet communication services to link medical services
users with providers. The principal terms of the acquisition require
the company to issue 26.25 million fully paid ordinary shares
("Vendor Shares") and to fund the first $450,000 of expenditure to
develop the business.
Additional terms include:-

(i) A two year option to acquire an additional 20% of the issued
capital of GDL. The consideration for this additional interest shall
be based on an independent valuation of GDL at the time the option is
exercised.

(ii) A first right of refusal over the remaining 20% of GDL shares.

(iii) The Vendor Shares will be subject to a voluntary
escrow period of 12 months.

(iv) If the software acquired by the Company pursuant to the
agreement is not operating satisfactorily within 6 months, then one
third of the Vendor Shares will be cancelled. In addition, if trials
at two overseas sites are not satisfactorily completed within 12
months, then one third of the Vendor Shares will be cancelled (a
total of two thirds of the Vendor Shares therefore being
cancellable).

During the quarter senior executives of the Global Doctor team have
visited a number of Asian capital cities and tourist destinations to
assess the market potential for the Global Doctor medical service. In
addition, licences have been negotiated and the clinic fitout
completed for the company`s Chengdu clinic. This was followed by
successful technical trials of its video conferencing and
telemedicine equipment from its first clinic in Chengdu, the capital
of Sichuan, China. GDL has recently appointed Dr Mike Galvin as a
director of the company who has been appointed Chief Medical Officer
of GDL. Senior medical staff have been engaged for its Perth base
which will enable delivery of a western general practice service with
Australian based doctors. GDL has made progress in seeking the
necessary approvals from the Chinese government for the Chengdu
clinic. GDL proposes to set up further clinics in Asia and GDL is in
the process of seeking the necessary government approvals, staff and
offices.

TERREX PROJECTS - ASIA
Putao, Kawttabun and Mt Loimye Prospecting Licences, Myanmar
(Terrex Resources Limited 51%)

Fieldwork recommenced late in the quarter following the end of the
heavy rains which affects all of the licence areas. Limited further
stream sediment sampling will be undertaken in areas showing
geological interest.

Samples from the last field season are in Yangon awaiting dispatch to
Perth. An application for an export permit has been applied for.

Compilation of all field data and mapping has been completed and once
assay results are available an appropriate detailed follow up
programme will be developed.

THAILAND

One granted SPL and three SPL applications in Central Thailand.
Terrex his a carried 5 - 10% indirect interest

No Fieldwork was undertaken during the current quarter pending the
end of the wet season. An agreement was reached on 31 December 1999
with a Thai company to farm-out the company`s mineral interests in
Thailand. In exchange, the Thai company will continue to carry on
active exploration work on the tenements at no cost to Terrex and,
should such exploration work locate a mineral resource, the Company
may elect to participate in the development of the resource with a
contributing interest of between 5% and 10%.

Your Directors consider this agreement will give the company
excellent exposure to extensions to the Chatree deposit which is
contiguous to some of Terrex`s SPL applications. Kingsgate has
recently published a final, very positive, feasibility study on the
Chatree gold deposit and has secured development finance for
construction of the mine.

TERREX PROJECTS - AUSTRALIA
SOUTHDOWN MAGNETITE - WA M70/718, M70/719, M70/433, R70/21
(Terrex Resources Limited 100%)

Discussions are well advanced to exchange the Company`s 100% interest
in the Southdown magnetite deposit for a royalty interest.

KAISER PROJECT - N.S.W.

Terrex has transferred its registered interest in two PL`s in this
project to its operating joint venture partners Ajax and Compass.
Terrex holds no direct interest in the two PL`s, and continues to
retain its entitlement to a $100,000 payment in the event of future
production.

INVESTMENTS - OMAX RESOURCES LTD, listed in Vancouver

Terrex owns 2.5 million Omax shares comprising 13.1% of the capital,
with a present market value of approximately $360,000.

Omax is presently drilling several hydrocarbon wells at projects
located in Ontario and Southern Alberta, Canada. Omax has between 10%
and 100% interest in the projects. Several gas and condensate
discoveries have been made and recent gas flows, following fracturing
and completion work, have been encouraging. Testing is continuing and
additional wells are planned under the current programs. Omax
presently has approximately C$2 million working capital and no debt.

CORPORATE

Changes to Board of Directors

On 5 October 1999 the Company announced the appointment of Mr Klaus
Eckhof to the Board. Mr Eckhof replaced Mr David Benham who retired
from the Company`s Board of Directors.

Options Issue

In December 1999 the company granted 200,089,786 options pursuant to
an underwritten pro-rata non renounceable rights issue. The options,
which were issued at a price of half a cent each, may be exercised at
any time on or before 31 December 2002 by payment of 20 cents each.
The issue raised $950,449 which will be used to assist with
development of the Company`s medical communications business and
existing mineral properties and for working capital. The issue was
underwritten for a fee comprising $5,000 in cash and the issue of 10
million options.

Share Issues

The company issued 26.25 million ordinary fully paid shares to the
vendor of Global Doctor Limited pursuant to the terms of the share
purchase agreement under which the company acquired its 60% interest.

1.5 million ordinary fully paid shares were issued to the vendors of
the company`s interest in the Myanmar mineral properties. These
shares were issued pursuant to the terms of the Heads of Agreement
dated 27th October 1998 following completion of certain conditions
precedent.

Change of Company Status

During the quarter the Company changed its status from a "no
liability" company to a "company limited by shares" and is now known
by its new name of Terrex Resources Limited.

ASX Code: TXR

SEATS Abbreviation: TERREX RES


G Argyle
DIRECTOR

MORE TO FOLLOW



TERREX RESOURCES LIMITED 2000-01-31 ASX-SIGNAL-G

HOMEX - Perth

+++++++++++++++++++++++++
MINING EXPLORATION ENTITY QUARTERLY REPORT

Name of entity
Terrex Resources Limited

ACN or ARBN Quarter ended ("current quarter")
007 553 979 31/12/1999

CONSOLIDATED STATEMENT OF CASH FLOWS

Cash flows related to Current Year to date
operating activities Quarter (12 months)
AUD`000 AUD`000
1.1 Receipts from product sales
and related debtors - -
1.2 Payments for
(a) exploration and evaluation 84 339
(b) development - -
(c) production - -
(d) administration 57 205
1.3 Dividends received - -
1.4 Interest and other items of
a similar nature received (28) (68)
1.5 Interest and other costs of
finance paid - -
1.6 Income taxes paid
1.7 Other - working capital changes - (7)

Net Operating Cash Flows 113 469

Cash flows related to investing activities
1.8 Payment for purchases of: - -
(b) equity investments - 41
(c) other fixed assets 1 17
1.9 Proceeds from sale of:
(a) prospects - -
(b) equity investments - -
(c) other fixed assets - -
1.10 Loans to other entities - -
1.11 Loans repaid by other entities - -
1.12 Other - Global Doctor developments costs 398 569

Net investing cash flows 399 627

1.13 Total operating and
investing cash flows 512 1,096

Cash flows related to financing activities
1.14 Proceeds from issues of
shares, options, etc. 945 3,587
1.15 Proceeds from sale of
forfeited shares - 68
1.16 Proceeds from borrowings - -
1.17 Repayment of borrowings - -
1.18 Dividends paid - -
1.19 Other (provide details if material) - (3)

Net financing cash flows 945 3,652

Net increase (decrease) in cash held 433 2,556

1.20 Cash at beginning of quarter/
year to date 2,244 121

1.21 Exchange rate adjustments to item 1.20 - -

1.22 Cash at end of quarter 2,677 2,677


PAYMENTS TO DIRECTORS OF THE ENTITY AND ASSOCIATES OF THE DIRECTORS
PAYMENTS TO RELATED ENTITIES AND ASSOCIATES OF THE RELATED ENTITIES

Current Quarter
AUD`000

1.23 Aggregate amount of payments to
the parties included in item 1.2 80

1.24 Aggregate amount of loans to the
parties included in item 1.10 -

1.25 Explanation necessary for an understanding
of the transactions

Comprises payments to Directors for fees and management services
totalling $77,000 and accounting services $3,000.

NON-CASH FINANCING AND INVESTING ACTIVITIES

2.1 Details of financing and investing transactions which have had a
material effect on consolidated assets and liabilities but did
not involve cash flows

* 26.25 million ordinary fully paid shares were issued to the vendor
of Global Doctor Limited pursuant to the terms of the relevant
share purchase agreement.

* 1.5 million ordinary fully paid shares wre issued to the vendors of
the company`s interest in the Myanmar mineral properties pursuant
to the terms of the relevant agreement.

* 10 million options were issued to the Underwriter of the
non-renounceable rights issue.

2.2 Details of outlays made by other entities to establish or
increase their share in projects in which the reporting entity
has an interest

-


FINANCING FACILITIES AVAILABLE
Add notes as necessary for an understanding of the position.

Amount Amount
available used
AUD`000 AUD`000

3.1 Loan facilities - -
3.2 Credit standby arrangements - -


ESTIMATED CASH OUTFLOWS FOR NEXT QUARTER AUD`000

4.1 Exploration and evaluation 100
4.2 Development -

Total 100


RECONCILIATION OF CASH

Reconciliation of cash at the end Current Previous
of the quarter (as shown in the quarter quarter
consolidated statement of cash flows) AUD`000 AUD`000
to the related items in the accounts
is as follows.

5.1 Cash on hand and at bank 9 142
5.2 Deposits at call 2,664 2,098
5.3 Bank overdraft - -
5.4 Other (provide details) 4 4

Total: cash at end of quarter (item 1.22) 2,677 2,244


CHANGES IN INTERESTS IN MINING TENEMENTS

Tenement Nature of Interest at Interest
reference interest beginning at end of
(note(2)) of quarter quarter

6.1 Interests in
mining tenements
relinquished,
reduced or lapsed Thailand Farm-out - 100% 5-10%
company may
elect to
participate
should an
economic
resource be
found.

6.2 Interests in
mining tenements
acquired or
increased - - - -


ISSUED AND QUOTED SECURITIES AT END OF CURRENT QUARTER
Description includes rate of interest and any redemption or conversion
rights together with prices and dates.

Category of Number Number Par value Paid-up
securities issued quoted (cents) value
(cents)
7.1 Preference
securities
(description) - - - -

7.2 Issued during
quarter - - - -

7.3 Ordinary
securities 285,134,680 285,134,680 - -

7.4 Issued during
quarter 1,500,000 1,500,000 4.0 -
26,250,000 26,250,000 2.0 -

7.5 Convertible debt
securities
(description) - - - -

7.6 Issued during
quarter - - - -

7.7 Options Exercise Expiry
(description) price date
(cents)

200,089,786 200,089,786 20 31/12/2002

7.8 Issued during
quarter 200,089,786 200,089,786 20 31/12/2002

7.9 Exercised during
quarter - - - -

7.10 Expired during
quarter - - - -

7.11 Debentures
(totals only) - -

7.12 Unsecured notes
(totals only) - -


COMPLIANCE STATEMENT

1 This statement has been prepared under accounting policies which
comply with accounting standards as defined in the Corporations Law
or other standards acceptable to ASX.

2 This statement does give a true and fair view
of the matters disclosed.

P R Baird Date: 31/01/2000
COMPANY SECRETARY
__________________________________________________

Announcement ASX:   2.2.00
The Board of Terrex Resources Limited is pleased to announce the
appointment of Dr Mike Galvin to the Board, Dr Galvin replaces Mr
Peter Baird, who has resigned from the company`s Board of Directors.

Dr Mike Galvin RFD, DTM&H, FRACGP, FACEM has over 25 years
experience practicing medicine and has held key positions in both
civilian and military hospitals. Dr Galvin has recently held post of
CEO, Fremantle Hospital. During his career, Dr Galvin has held post
as Director of Clinical Services and Director of Emergency Medicine,
Principal Medical Office Australia (RAAF). In addition to the many
medical fellowships and memberships, Dr Galvin is an Emeritus
Consultant in Emergency Medicine to Fremantle Hospital and has
Diplomas in Tropical Medicine and Hygiene and Aerospace Medicine.


....gepostet gestern im Wallstreet-Board.

Für mich klingt das nicht gerade schlecht. Was sagt Ihr dazu?

Gruss, Synapse
 

TERREX RESOURCES LIMITED (TXR)
(Company background)
Fourth Quarter Activities & Cashflow Report
Announced on 2000/02/02 16:10:17.
Part:B 1075 words
Status: Market sensitive (Y)
Industry Sub Group: Gold Explorer (12)



TERREX RESOURCES LIMITED 2000-01-31 ASX-SIGNAL-G

HOMEX - Perth

+++++++++++++++++++++++++
ACQUISITION OF INTEREST IN GLOBAL DOCTOR LTD

In August 1999 the company announced the acquisition of a 60%
interest in the capital of Global Doctor Limited ("GDL"), a company
which intends to participate in the medical industry through the
provision of internet communication services to link medical services
users with providers. The principal terms of the acquisition require
the company to issue 26.25 million fully paid ordinary shares
("Vendor Shares") and to fund the first $450,000 of expenditure to
develop the business.
Additional terms include:-

(i) A two year option to acquire an additional 20% of the issued
capital of GDL. The consideration for this additional interest shall
be based on an independent valuation of GDL at the time the option is
exercised.

(ii) A first right of refusal over the remaining 20% of GDL shares.

(iii) The Vendor Shares will be subject to a voluntary
escrow period of 12 months.

(iv) If the software acquired by the Company pursuant to the
agreement is not operating satisfactorily within 6 months, then one
third of the Vendor Shares will be cancelled. In addition, if trials
at two overseas sites are not satisfactorily completed within 12
months, then one third of the Vendor Shares will be cancelled (a
total of two thirds of the Vendor Shares therefore being
cancellable).

During the quarter senior executives of the Global Doctor team have
visited a number of Asian capital cities and tourist destinations to
assess the market potential for the Global Doctor medical service. In
addition, licences have been negotiated and the clinic fitout
completed for the company`s Chengdu clinic. This was followed by
successful technical trials of its video conferencing and
telemedicine equipment from its first clinic in Chengdu, the capital
of Sichuan, China. GDL has recently appointed Dr Mike Galvin as a
director of the company who has been appointed Chief Medical Officer
of GDL. Senior medical staff have been engaged for its Perth base
which will enable delivery of a western general practice service with
Australian based doctors. GDL has made progress in seeking the
necessary approvals from the Chinese government for the Chengdu
clinic. GDL proposes to set up further clinics in Asia and GDL is in
the process of seeking the necessary government approvals, staff and
offices.

TERREX PROJECTS - ASIA
Putao, Kawttabun and Mt Loimye Prospecting Licences, Myanmar
(Terrex Resources Limited 51%)

Fieldwork recommenced late in the quarter following the end of the
heavy rains which affects all of the licence areas. Limited further
stream sediment sampling will be undertaken in areas showing
geological interest.

Samples from the last field season are in Yangon awaiting dispatch to
Perth. An application for an export permit has been applied for.

Compilation of all field data and mapping has been completed and once
assay results are available an appropriate detailed follow up
programme will be developed.

THAILAND

One granted SPL and three SPL applications in Central Thailand.
Terrex his a carried 5 - 10% indirect interest

No Fieldwork was undertaken during the current quarter pending the
end of the wet season. An agreement was reached on 31 December 1999
with a Thai company to farm-out the company`s mineral interests in
Thailand. In exchange, the Thai company will continue to carry on
active exploration work on the tenements at no cost to Terrex and,
should such exploration work locate a mineral resource, the Company
may elect to participate in the development of the resource with a
contributing interest of between 5% and 10%.

Your Directors consider this agreement will give the company
excellent exposure to extensions to the Chatree deposit which is
contiguous to some of Terrex`s SPL applications. Kingsgate has
recently published a final, very positive, feasibility study on the
Chatree gold deposit and has secured development finance for
construction of the mine.

TERREX PROJECTS - AUSTRALIA
SOUTHDOWN MAGNETITE - WA M70/718, M70/719, M70/433, R70/21
(Terrex Resources Limited 100%)

Discussions are well advanced to exchange the Company`s 100% interest
in the Southdown magnetite deposit for a royalty interest.

KAISER PROJECT - N.S.W.

Terrex has transferred its registered interest in two PL`s in this
project to its operating joint venture partners Ajax and Compass.
Terrex holds no direct interest in the two PL`s, and continues to
retain its entitlement to a $100,000 payment in the event of future
production.

INVESTMENTS - OMAX RESOURCES LTD, listed in Vancouver

Terrex owns 2.5 million Omax shares comprising 13.1% of the capital,
with a present market value of approximately $360,000.

Omax is presently drilling several hydrocarbon wells at projects
located in Ontario and Southern Alberta, Canada. Omax has between 10%
and 100% interest in the projects. Several gas and condensate
discoveries have been made and recent gas flows, following fracturing
and completion work, have been encouraging. Testing is continuing and
additional wells are planned under the current programs. Omax
presently has approximately C$2 million working capital and no debt.

CORPORATE

Changes to Board of Directors

On 5 October 1999 the Company announced the appointment of Mr Klaus
Eckhof to the Board. Mr Eckhof replaced Mr David Benham who retired
from the Company`s Board of Directors.

Options Issue

In December 1999 the company granted 200,089,786 options pursuant to
an underwritten pro-rata non renounceable rights issue. The options,
which were issued at a price of half a cent each, may be exercised at
any time on or before 31 December 2002 by payment of 20 cents each.
The issue raised $950,449 which will be used to assist with
development of the Company`s medical communications business and
existing mineral properties and for working capital. The issue was
underwritten for a fee comprising $5,000 in cash and the issue of 10
million options.

Share Issues

The company issued 26.25 million ordinary fully paid shares to the
vendor of Global Doctor Limited pursuant to the terms of the share
purchase agreement under which the company acquired its 60% interest.

1.5 million ordinary fully paid shares were issued to the vendors of
the company`s interest in the Myanmar mineral properties. These
shares were issued pursuant to the terms of the Heads of Agreement
dated 27th October 1998 following completion of certain conditions
precedent.

Change of Company Status

During the quarter the Company changed its status from a "no
liability" company to a "company limited by shares" and is now known
by its new name of Terrex Resources Limited.

ASX Code: TXR

SEATS Abbreviation: TERREX RES


G Argyle
DIRECTOR

MORE TO FOLLOW



TERREX RESOURCES LIMITED 2000-01-31 ASX-SIGNAL-G

HOMEX - Perth

+++++++++++++++++++++++++
MINING EXPLORATION ENTITY QUARTERLY REPORT

Name of entity
Terrex Resources Limited

ACN or ARBN Quarter ended ("current quarter")
007 553 979 31/12/1999

CONSOLIDATED STATEMENT OF CASH FLOWS

Cash flows related to Current Year to date
operating activities Quarter (12 months)
AUD`000 AUD`000
1.1 Receipts from product sales
and related debtors - -
1.2 Payments for
(a) exploration and evaluation 84 339
(b) development - -
(c) production - -
(d) administration 57 205
1.3 Dividends received - -
1.4 Interest and other items of
a similar nature received (28) (68)
1.5 Interest and other costs of
finance paid - -
1.6 Income taxes paid
1.7 Other - working capital changes - (7)

Net Operating Cash Flows 113 469

Cash flows related to investing activities
1.8 Payment for purchases of: - -
(b) equity investments - 41
(c) other fixed assets 1 17
1.9 Proceeds from sale of:
(a) prospects - -
(b) equity investments - -
(c) other fixed assets - -
1.10 Loans to other entities - -
1.11 Loans repaid by other entities - -
1.12 Other - Global Doctor developments costs 398 569

Net investing cash flows 399 627

1.13 Total operating and
investing cash flows 512 1,096

Cash flows related to financing activities
1.14 Proceeds from issues of
shares, options, etc. 945 3,587
1.15 Proceeds from sale of
forfeited shares - 68
1.16 Proceeds from borrowings - -
1.17 Repayment of borrowings - -
1.18 Dividends paid - -
1.19 Other (provide details if material) - (3)

Net financing cash flows 945 3,652

Net increase (decrease) in cash held 433 2,556

1.20 Cash at beginning of quarter/
year to date 2,244 121

1.21 Exchange rate adjustments to item 1.20 - -

1.22 Cash at end of quarter 2,677 2,677


PAYMENTS TO DIRECTORS OF THE ENTITY AND ASSOCIATES OF THE DIRECTORS
PAYMENTS TO RELATED ENTITIES AND ASSOCIATES OF THE RELATED ENTITIES

Current Quarter
AUD`000

1.23 Aggregate amount of payments to
the parties included in item 1.2 80

1.24 Aggregate amount of loans to the
parties included in item 1.10 -

1.25 Explanation necessary for an understanding
of the transactions

Comprises payments to Directors for fees and management services
totalling $77,000 and accounting services $3,000.

NON-CASH FINANCING AND INVESTING ACTIVITIES

2.1 Details of financing and investing transactions which have had a
material effect on consolidated assets and liabilities but did
not involve cash flows

* 26.25 million ordinary fully paid shares were issued to the vendor
of Global Doctor Limited pursuant to the terms of the relevant
share purchase agreement.

* 1.5 million ordinary fully paid shares wre issued to the vendors of
the company`s interest in the Myanmar mineral properties pursuant
to the terms of the relevant agreement.

* 10 million options were issued to the Underwriter of the
non-renounceable rights issue.

2.2 Details of outlays made by other entities to establish or
increase their share in projects in which the reporting entity
has an interest

-


FINANCING FACILITIES AVAILABLE
Add notes as necessary for an understanding of the position.

Amount Amount
available used
AUD`000 AUD`000

3.1 Loan facilities - -
3.2 Credit standby arrangements - -


ESTIMATED CASH OUTFLOWS FOR NEXT QUARTER AUD`000

4.1 Exploration and evaluation 100
4.2 Development -

Total 100


RECONCILIATION OF CASH

Reconciliation of cash at the end Current Previous
of the quarter (as shown in the quarter quarter
consolidated statement of cash flows) AUD`000 AUD`000
to the related items in the accounts
is as follows.

5.1 Cash on hand and at bank 9 142
5.2 Deposits at call 2,664 2,098
5.3 Bank overdraft - -
5.4 Other (provide details) 4 4

Total: cash at end of quarter (item 1.22) 2,677 2,244


CHANGES IN INTERESTS IN MINING TENEMENTS

Tenement Nature of Interest at Interest
reference interest beginning at end of
(note(2)) of quarter quarter

6.1 Interests in
mining tenements
relinquished,
reduced or lapsed Thailand Farm-out - 100% 5-10%
company may
elect to
participate
should an
economic
resource be
found.

6.2 Interests in
mining tenements
acquired or
increased - - - -


ISSUED AND QUOTED SECURITIES AT END OF CURRENT QUARTER
Description includes rate of interest and any redemption or conversion
rights together with prices and dates.

Category of Number Number Par value Paid-up
securities issued quoted (cents) value
(cents)
7.1 Preference
securities
(description) - - - -

7.2 Issued during
quarter - - - -

7.3 Ordinary
securities 285,134,680 285,134,680 - -

7.4 Issued during
quarter 1,500,000 1,500,000 4.0 -
26,250,000 26,250,000 2.0 -

7.5 Convertible debt
securities
(description) - - - -

7.6 Issued during
quarter - - - -

7.7 Options Exercise Expiry
(description) price date
(cents)

200,089,786 200,089,786 20 31/12/2002

7.8 Issued during
quarter 200,089,786 200,089,786 20 31/12/2002

7.9 Exercised during
quarter - - - -

7.10 Expired during
quarter - - - -

7.11 Debentures
(totals only) - -

7.12 Unsecured notes
(totals only) - -


COMPLIANCE STATEMENT

1 This statement has been prepared under accounting policies which
comply with accounting standards as defined in the Corporations Law
or other standards acceptable to ASX.

2 This statement does give a true and fair view
of the matters disclosed.

P R Baird Date: 31/01/2000
COMPANY SECRETARY
__________________________________________________

Announcement ASX:   2.2.00
The Board of Terrex Resources Limited is pleased to announce the
appointment of Dr Mike Galvin to the Board, Dr Galvin replaces Mr
Peter Baird, who has resigned from the company`s Board of Directors.

Dr Mike Galvin RFD, DTM&H, FRACGP, FACEM has over 25 years
experience practicing medicine and has held key positions in both
civilian and military hospitals. Dr Galvin has recently held post of
CEO, Fremantle Hospital. During his career, Dr Galvin has held post
as Director of Clinical Services and Director of Emergency Medicine,
Principal Medical Office Australia (RAAF). In addition to the many
medical fellowships and memberships, Dr Galvin is an Emeritus
Consultant in Emergency Medicine to Fremantle Hospital and has
Diplomas in Tropical Medicine and Hygiene and Aerospace Medicine.


....gepostet gestern im Wallstreet-Board.

Das klingt für mich beim besten Willen nicht nach Weltuntergangsstimmung. Spätestens Ende Februar werden die abgehen!

Gruss Synapse
 

TERREX RESOURCES LIMITED (TXR)
(Company background)
Fourth Quarter Activities & Cashflow Report
Announced on 2000/02/02 16:10:17.
Part:B 1075 words
Status: Market sensitive (Y)
Industry Sub Group: Gold Explorer (12)



TERREX RESOURCES LIMITED 2000-01-31 ASX-SIGNAL-G

HOMEX - Perth

+++++++++++++++++++++++++
ACQUISITION OF INTEREST IN GLOBAL DOCTOR LTD

In August 1999 the company announced the acquisition of a 60%
interest in the capital of Global Doctor Limited ("GDL"), a company
which intends to participate in the medical industry through the
provision of internet communication services to link medical services
users with providers. The principal terms of the acquisition require
the company to issue 26.25 million fully paid ordinary shares
("Vendor Shares") and to fund the first $450,000 of expenditure to
develop the business.
Additional terms include:-

(i) A two year option to acquire an additional 20% of the issued
capital of GDL. The consideration for this additional interest shall
be based on an independent valuation of GDL at the time the option is
exercised.

(ii) A first right of refusal over the remaining 20% of GDL shares.

(iii) The Vendor Shares will be subject to a voluntary
escrow period of 12 months.

(iv) If the software acquired by the Company pursuant to the
agreement is not operating satisfactorily within 6 months, then one
third of the Vendor Shares will be cancelled. In addition, if trials
at two overseas sites are not satisfactorily completed within 12
months, then one third of the Vendor Shares will be cancelled (a
total of two thirds of the Vendor Shares therefore being
cancellable).

During the quarter senior executives of the Global Doctor team have
visited a number of Asian capital cities and tourist destinations to
assess the market potential for the Global Doctor medical service. In
addition, licences have been negotiated and the clinic fitout
completed for the company`s Chengdu clinic. This was followed by
successful technical trials of its video conferencing and
telemedicine equipment from its first clinic in Chengdu, the capital
of Sichuan, China. GDL has recently appointed Dr Mike Galvin as a
director of the company who has been appointed Chief Medical Officer
of GDL. Senior medical staff have been engaged for its Perth base
which will enable delivery of a western general practice service with
Australian based doctors. GDL has made progress in seeking the
necessary approvals from the Chinese government for the Chengdu
clinic. GDL proposes to set up further clinics in Asia and GDL is in
the process of seeking the necessary government approvals, staff and
offices.

TERREX PROJECTS - ASIA
Putao, Kawttabun and Mt Loimye Prospecting Licences, Myanmar
(Terrex Resources Limited 51%)

Fieldwork recommenced late in the quarter following the end of the
heavy rains which affects all of the licence areas. Limited further
stream sediment sampling will be undertaken in areas showing
geological interest.

Samples from the last field season are in Yangon awaiting dispatch to
Perth. An application for an export permit has been applied for.

Compilation of all field data and mapping has been completed and once
assay results are available an appropriate detailed follow up
programme will be developed.

THAILAND

One granted SPL and three SPL applications in Central Thailand.
Terrex his a carried 5 - 10% indirect interest

No Fieldwork was undertaken during the current quarter pending the
end of the wet season. An agreement was reached on 31 December 1999
with a Thai company to farm-out the company`s mineral interests in
Thailand. In exchange, the Thai company will continue to carry on
active exploration work on the tenements at no cost to Terrex and,
should such exploration work locate a mineral resource, the Company
may elect to participate in the development of the resource with a
contributing interest of between 5% and 10%.

Your Directors consider this agreement will give the company
excellent exposure to extensions to the Chatree deposit which is
contiguous to some of Terrex`s SPL applications. Kingsgate has
recently published a final, very positive, feasibility study on the
Chatree gold deposit and has secured development finance for
construction of the mine.

TERREX PROJECTS - AUSTRALIA
SOUTHDOWN MAGNETITE - WA M70/718, M70/719, M70/433, R70/21
(Terrex Resources Limited 100%)

Discussions are well advanced to exchange the Company`s 100% interest
in the Southdown magnetite deposit for a royalty interest.

KAISER PROJECT - N.S.W.

Terrex has transferred its registered interest in two PL`s in this
project to its operating joint venture partners Ajax and Compass.
Terrex holds no direct interest in the two PL`s, and continues to
retain its entitlement to a $100,000 payment in the event of future
production.

INVESTMENTS - OMAX RESOURCES LTD, listed in Vancouver

Terrex owns 2.5 million Omax shares comprising 13.1% of the capital,
with a present market value of approximately $360,000.

Omax is presently drilling several hydrocarbon wells at projects
located in Ontario and Southern Alberta, Canada. Omax has between 10%
and 100% interest in the projects. Several gas and condensate
discoveries have been made and recent gas flows, following fracturing
and completion work, have been encouraging. Testing is continuing and
additional wells are planned under the current programs. Omax
presently has approximately C$2 million working capital and no debt.

CORPORATE

Changes to Board of Directors

On 5 October 1999 the Company announced the appointment of Mr Klaus
Eckhof to the Board. Mr Eckhof replaced Mr David Benham who retired
from the Company`s Board of Directors.

Options Issue

In December 1999 the company granted 200,089,786 options pursuant to
an underwritten pro-rata non renounceable rights issue. The options,
which were issued at a price of half a cent each, may be exercised at
any time on or before 31 December 2002 by payment of 20 cents each.
The issue raised $950,449 which will be used to assist with
development of the Company`s medical communications business and
existing mineral properties and for working capital. The issue was
underwritten for a fee comprising $5,000 in cash and the issue of 10
million options.

Share Issues

The company issued 26.25 million ordinary fully paid shares to the
vendor of Global Doctor Limited pursuant to the terms of the share
purchase agreement under which the company acquired its 60% interest.

1.5 million ordinary fully paid shares were issued to the vendors of
the company`s interest in the Myanmar mineral properties. These
shares were issued pursuant to the terms of the Heads of Agreement
dated 27th October 1998 following completion of certain conditions
precedent.

Change of Company Status

During the quarter the Company changed its status from a "no
liability" company to a "company limited by shares" and is now known
by its new name of Terrex Resources Limited.

ASX Code: TXR

SEATS Abbreviation: TERREX RES


G Argyle
DIRECTOR

MORE TO FOLLOW



TERREX RESOURCES LIMITED 2000-01-31 ASX-SIGNAL-G

HOMEX - Perth

+++++++++++++++++++++++++
MINING EXPLORATION ENTITY QUARTERLY REPORT

Name of entity
Terrex Resources Limited

ACN or ARBN Quarter ended ("current quarter")
007 553 979 31/12/1999

CONSOLIDATED STATEMENT OF CASH FLOWS

Cash flows related to Current Year to date
operating activities Quarter (12 months)
AUD`000 AUD`000
1.1 Receipts from product sales
and related debtors - -
1.2 Payments for
(a) exploration and evaluation 84 339
(b) development - -
(c) production - -
(d) administration 57 205
1.3 Dividends received - -
1.4 Interest and other items of
a similar nature received (28) (68)
1.5 Interest and other costs of
finance paid - -
1.6 Income taxes paid
1.7 Other - working capital changes - (7)

Net Operating Cash Flows 113 469

Cash flows related to investing activities
1.8 Payment for purchases of: - -
(b) equity investments - 41
(c) other fixed assets 1 17
1.9 Proceeds from sale of:
(a) prospects - -
(b) equity investments - -
(c) other fixed assets - -
1.10 Loans to other entities - -
1.11 Loans repaid by other entities - -
1.12 Other - Global Doctor developments costs 398 569

Net investing cash flows 399 627

1.13 Total operating and
investing cash flows 512 1,096

Cash flows related to financing activities
1.14 Proceeds from issues of
shares, options, etc. 945 3,587
1.15 Proceeds from sale of
forfeited shares - 68
1.16 Proceeds from borrowings - -
1.17 Repayment of borrowings - -
1.18 Dividends paid - -
1.19 Other (provide details if material) - (3)

Net financing cash flows 945 3,652

Net increase (decrease) in cash held 433 2,556

1.20 Cash at beginning of quarter/
year to date 2,244 121

1.21 Exchange rate adjustments to item 1.20 - -

1.22 Cash at end of quarter 2,677 2,677


PAYMENTS TO DIRECTORS OF THE ENTITY AND ASSOCIATES OF THE DIRECTORS
PAYMENTS TO RELATED ENTITIES AND ASSOCIATES OF THE RELATED ENTITIES

Current Quarter
AUD`000

1.23 Aggregate amount of payments to
the parties included in item 1.2 80

1.24 Aggregate amount of loans to the
parties included in item 1.10 -

1.25 Explanation necessary for an understanding
of the transactions

Comprises payments to Directors for fees and management services
totalling $77,000 and accounting services $3,000.

NON-CASH FINANCING AND INVESTING ACTIVITIES

2.1 Details of financing and investing transactions which have had a
material effect on consolidated assets and liabilities but did
not involve cash flows

* 26.25 million ordinary fully paid shares were issued to the vendor
of Global Doctor Limited pursuant to the terms of the relevant
share purchase agreement.

* 1.5 million ordinary fully paid shares wre issued to the vendors of
the company`s interest in the Myanmar mineral properties pursuant
to the terms of the relevant agreement.

* 10 million options were issued to the Underwriter of the
non-renounceable rights issue.

2.2 Details of outlays made by other entities to establish or
increase their share in projects in which the reporting entity
has an interest

-


FINANCING FACILITIES AVAILABLE
Add notes as necessary for an understanding of the position.

Amount Amount
available used
AUD`000 AUD`000

3.1 Loan facilities - -
3.2 Credit standby arrangements - -


ESTIMATED CASH OUTFLOWS FOR NEXT QUARTER AUD`000

4.1 Exploration and evaluation 100
4.2 Development -

Total 100


RECONCILIATION OF CASH

Reconciliation of cash at the end Current Previous
of the quarter (as shown in the quarter quarter
consolidated statement of cash flows) AUD`000 AUD`000
to the related items in the accounts
is as follows.

5.1 Cash on hand and at bank 9 142
5.2 Deposits at call 2,664 2,098
5.3 Bank overdraft - -
5.4 Other (provide details) 4 4

Total: cash at end of quarter (item 1.22) 2,677 2,244


CHANGES IN INTERESTS IN MINING TENEMENTS

Tenement Nature of Interest at Interest
reference interest beginning at end of
(note(2)) of quarter quarter

6.1 Interests in
mining tenements
relinquished,
reduced or lapsed Thailand Farm-out - 100% 5-10%
company may
elect to
participate
should an
economic
resource be
found.

6.2 Interests in
mining tenements
acquired or
increased - - - -


ISSUED AND QUOTED SECURITIES AT END OF CURRENT QUARTER
Description includes rate of interest and any redemption or conversion
rights together with prices and dates.

Category of Number Number Par value Paid-up
securities issued quoted (cents) value
(cents)
7.1 Preference
securities
(description) - - - -

7.2 Issued during
quarter - - - -

7.3 Ordinary
securities 285,134,680 285,134,680 - -

7.4 Issued during
quarter 1,500,000 1,500,000 4.0 -
26,250,000 26,250,000 2.0 -

7.5 Convertible debt
securities
(description) - - - -

7.6 Issued during
quarter - - - -

7.7 Options Exercise Expiry
(description) price date
(cents)

200,089,786 200,089,786 20 31/12/2002

7.8 Issued during
quarter 200,089,786 200,089,786 20 31/12/2002

7.9 Exercised during
quarter - - - -

7.10 Expired during
quarter - - - -

7.11 Debentures
(totals only) - -

7.12 Unsecured notes
(totals only) - -


COMPLIANCE STATEMENT

1 This statement has been prepared under accounting policies which
comply with accounting standards as defined in the Corporations Law
or other standards acceptable to ASX.

2 This statement does give a true and fair view
of the matters disclosed.

P R Baird Date: 31/01/2000
COMPANY SECRETARY
__________________________________________________

Announcement ASX:   2.2.00
The Board of Terrex Resources Limited is pleased to announce the
appointment of Dr Mike Galvin to the Board, Dr Galvin replaces Mr
Peter Baird, who has resigned from the company`s Board of Directors.

Dr Mike Galvin RFD, DTM&H, FRACGP, FACEM has over 25 years
experience practicing medicine and has held key positions in both
civilian and military hospitals. Dr Galvin has recently held post of
CEO, Fremantle Hospital. During his career, Dr Galvin has held post
as Director of Clinical Services and Director of Emergency Medicine,
Principal Medical Office Australia (RAAF). In addition to the many
medical fellowships and memberships, Dr Galvin is an Emeritus
Consultant in Emergency Medicine to Fremantle Hospital and has
Diplomas in Tropical Medicine and Hygiene and Aerospace Medicine.


....gepostet gestern im Wallstreet-Board.

Das klingt für mich beim besten Willen nicht nach Weltuntergangsstimmung. Spätestens Ende Februar werden die abgehen!

Gruss Synapse